A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus

BACKGROUND AND OBJECTIVES: Non-small-cell lung cancer (NSCLC) represents approximately 80% of all lung cancers. Unfortunately, at their time of diagnosis, most patients have advanced to unresectable disease with a very poor prognosis. The oriental herbal medicine HangAm-Plus(HAP) has been developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Bang, Sun-Hwi, Yoon, Jeung-Won, Cho, Chong-Kwan, Shin, Ji-Eun, Lee, Yeon-Weol, Yoo, Hwa-Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KOREAN PHARMACOPUNCTURE INSTITUTE 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331932/
https://www.ncbi.nlm.nih.gov/pubmed/25780640
http://dx.doi.org/10.3831/KPI.2012.15.2.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331932/
https://www.ncbi.nlm.nih.gov/pubmed/25780640
http://dx.doi.org/10.3831/KPI.2012.15.2.031

Ejemplares similares